The employer-sponsored health insurance landscape for GLP-1 medications is changing rapidly. In 2024, fewer than 25 percent of large employers covered GLP-1s for weight management. By mid-2026, that number is climbing — driven by emerging data showing that GLP-1 coverage reduces total healthcare costs.
Why Employers Are Adding Coverage
The economic argument has shifted. Early concerns about the cost of covering GLP-1 medications are being offset by emerging evidence of downstream savings. Employees on GLP-1 therapy show reductions in hospitalizations for cardiovascular events, fewer diabetes-related complications, reduced musculoskeletal claims (due to weight reduction), and lower rates of obesity-related surgical procedures.
Several large self-insured employers have reported that the net cost of adding GLP-1 coverage has been lower than projected, particularly when accounting for reduced utilization in other high-cost categories.
How to Check Your Employer's Coverage
Start with your plan's Summary of Benefits and Coverage (SBC) document. Look for mentions of weight-management medications, obesity pharmacotherapy, or specific drug names (semaglutide, tirzepatide, Wegovy, Zepbound, Mounjaro). If the SBC is unclear, call the member services number on your insurance card and ask specifically: "Does my plan cover FDA-approved medications for weight management?"
Open Enrollment Strategy
If your employer is considering adding GLP-1 coverage, it will most likely take effect at the next plan year. Open enrollment is typically in the fall for January 1 effective dates. Ask your HR or benefits team about upcoming formulary changes — some employers announce new coverage during open enrollment periods.
What Coverage Looks Like
Employer GLP-1 coverage typically includes prior authorization (the same PA process as other specialty drugs), formulary restrictions (may cover Wegovy but not Zepbound, or vice versa), step therapy requirements (try lifestyle modifications first), and specialty tier copays ranging from $25 to $200 per month after PA approval.
What Employers Are Not Covering
Most employer plans that cover GLP-1s for weight management still do not cover compounded versions. The coverage is for FDA-approved brand-name medications only. This means the PA process applies, and denial rates remain significant.
Sesame Care From $99/visit · Prescribes FDA-approved brand-name medications only. Accepts insurance. No subscription lock-in.
Prescribes FDA-approved brand-name medications only.
Oak Longevity $130/mo sema flat · Flat-rate pricing at any dose. $130/mo semaglutide, $199/mo tirzepatide. Free coaching. Cancel anytime.
⚕️ Compounded medications are not FDA-approved. They are prepared by licensed pharmacies under physician supervision.
Found Health From $129/mo · Evidence-based weight-care platform. Personalized GLP-1 prescriptions with board-certified physicians.
⚕️ Compounded medications are not FDA-approved. They are prepared by licensed pharmacies under physician supervision.
Advocating for Coverage at Your Workplace
If your employer does not currently cover GLP-1 medications, you can advocate for change through your HR or benefits team. Key talking points include the clinical evidence supporting GLP-1 therapy, the growing number of comparable employers adding coverage, the potential for reduced total healthcare costs, and employee retention and satisfaction benefits.
Some employers have added GLP-1 coverage in response to direct employee feedback during benefits survey periods.